Rizact
Intended to relieve throbbing migraine pain to support physical comfort and target cerebral vascular stability.
- Category
- Pain & Anti-inflammatories
- Active ingredient
- Rizatriptan
- Route
- Oral use
- Form
- Tablet
- Strengths
- 5mg · 10mg
Prescription and consultation requirements for Rizact vary by destination and are determined by the fulfilment partner.
Rizact details
- Condition
- Acute Migraine
- Alternative names
- rizatriptan
- Therapeutic class
- Selective Serotonin 5-HT1B/1D Receptor Agonist
- Pharmacological class
- Triptan
- Minor side effects
- dizziness; somnolence; nausea
- Moderate side effects
- fatigue; dry mouth; chest tightness
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 30–60 minutes
- Duration
- 4–6 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- MAO Inhibitors; Ergotamines; Propranolol
- Age restrictions
- Approved for children over six years and adults.
Contraindications
ischaemic coronary artery disease; uncontrolled hypertension; concurrent use of ergotamines; MAO inhibitor therapy
Serious side effects
coronary artery vasospasm, requires immediate medical attention; myocardial infarction, requires immediate medical attention
Patient summary
intended to relieve throbbing migraine pain to support physical comfort and target cerebral vascular stability.
Mechanism of action
Stimulates 5-HT1B and 5-HT1D receptors, narrowing expanded cranial vessels and blocking localised sensory pain transmission.
Pregnancy and breastfeeding
TGA Category C: Use if potential benefits exceed risks. Breastfeeding: Consult a clinician.